Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-ku, Tokyo 105-8461, Japan.
Metabolic Signal Research Center, Institute for Molecular and Cellular Regulation, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma 371-8512, Japan.
Int J Mol Sci. 2019 Jul 28;20(15):3699. doi: 10.3390/ijms20153699.
To date, type 2 diabetes is considered to be a "bi-hormonal disorder" rather than an "insulin-centric disorder," suggesting that glucagon is as important as insulin. Although glucagon increases hepatic glucose production and blood glucose levels, paradoxical glucagon hypersecretion is observed in diabetes. Recently, insulin resistance in pancreatic α cells has been proposed to be associated with glucagon dysregulation. Moreover, cell autonomous dysfunction of α cells is involved in the etiology of diabetes. In this review, we summarize the current knowledge about the physiological and pathological roles of glucagon.
迄今为止,2 型糖尿病被认为是一种“双激素紊乱”,而不是“以胰岛素为中心的紊乱”,这表明胰高血糖素与胰岛素同样重要。尽管胰高血糖素会增加肝葡萄糖生成和血糖水平,但在糖尿病中观察到胰高血糖素分泌过多的现象。最近,有人提出胰腺α细胞中的胰岛素抵抗与胰高血糖素失调有关。此外,α细胞的自主功能障碍也与糖尿病的病因有关。在这篇综述中,我们总结了目前关于胰高血糖素的生理和病理作用的知识。